The document discusses structure-based in-silico virtual screening protocols. It describes virtual screening as using computer methods to discover new ligands based on a target protein's biological structure. The main goal is to reduce the enormous chemical space of potential compounds to a manageable number with the highest likelihood of becoming drug candidates. Molecular docking is a key method, involving sampling potential ligand positions in the protein's binding site and scoring the interactions. The document also discusses force field, empirical, and knowledge-based scoring functions used to evaluate docking poses. Applications mentioned include designing Hsp90 inhibitors for cancer treatment and identifying novel BACE1 inhibitors.